These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36440772)

  • 21. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.
    Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H
    Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental data on lithium salts: From neuroprotection to multi-organ complications.
    Kakhki S; Ahmadi-Soleimani SM
    Life Sci; 2022 Oct; 306():120811. PubMed ID: 35850248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
    Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
    Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium: a novel treatment for Alzheimer's disease?
    Zhong J; Lee WH
    Expert Opin Drug Saf; 2007 Jul; 6(4):375-83. PubMed ID: 17688381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.
    Szulc A; Wiedlocha M; Waszkiewicz N; Galińska-Skok B; Marcinowicz P; Gierus J; Mosiolek A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():1-8. PubMed ID: 29414126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms and therapeutic potential of lithium in Alzheimer's disease: repurposing an old class of drugs.
    Shen Y; Zhao M; Zhao P; Meng L; Zhang Y; Zhang G; Taishi Y; Sun L
    Front Pharmacol; 2024; 15():1408462. PubMed ID: 39055498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with lithium efficacy in bipolar disorder.
    Rybakowski JK
    Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
    Malhi GS; Tanious M; Das P; Coulston CM; Berk M
    CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium.
    Singulani MP; De Paula VJR; Forlenza OV
    Neurosci Lett; 2021 Aug; 760():136078. PubMed ID: 34161823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
    Padiath QS; Paranjpe D; Jain S; Sharma VK
    Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does lithium prevent Alzheimer's disease?
    Forlenza OV; de Paula VJ; Machado-Vieira R; Diniz BS; Gattaz WF
    Drugs Aging; 2012 May; 29(5):335-42. PubMed ID: 22500970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models.
    Kerr F; Bjedov I; Sofola-Adesakin O
    Front Mol Neurosci; 2018; 11():297. PubMed ID: 30210290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lithium treatment alters the excitatory/ inhibitory balance of synaptic networks and reduces mGluR5-PKC signalling in mouse cortical neurons.
    Khayachi A; Ase A; Liao C; Kamesh A; Kuhlmann N; Schorova L; Chaumette B; Dion P; Alda M; Séguéla P; Rouleau G; Milnerwood A
    J Psychiatry Neurosci; 2021 Jun; 46(3):E402-E414. PubMed ID: 34077150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
    Chuang DM
    Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?
    Shaltiel G; Deutsch J; Rapoport SI; Basselin M; Belmaker RH; Agam G
    J Neural Transm (Vienna); 2009 Nov; 116(11):1543-9. PubMed ID: 19756369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and Dependence.
    Kitanaka N; Hall FS; Uhl GR; Kitanaka J
    Curr Drug Res Rev; 2019; 11(2):85-91. PubMed ID: 31875781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.